Your conspiracy theory about big pharmas blocking regulatory approval is pie in the sky, the real reason is amateurish bungles by the company. They have repeatedly sacked competent people working on their approvals and thus caused a breakdown in continuity, confusion and delays, then finally the appointment of a stooge in the position.
Pricing will not help the fact that competitors to the product are catching up and also that the product is not a full substitute for antibiotics but only a substitute for gastrointestinal problems.
- Forums
- ASX - By Stock
- CMQ
- why the pessimism
why the pessimism, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)